The New York Times (1/10, Richtel) reports, “Prescriptions for drugs used to treat attention deficit hyperactivity disorder surged during the coronavirus pandemic, particularly among women and patients ages 20 to 39, according to new research compiled by scholars affiliated with the” FDA. This “increase came as prescription rates held relatively steady for other key classes of behavioral health medications used to treat conditions such as depression and anxiety, according to the study.” The Times adds, “The reasons are not totally clear, the researchers found, and could include pandemic-related stress, recognition of undiagnosed cases, over-prescription and online marketing of medications.” The findings were published in JAMA Psychiatry.